シンバイオ製薬(株)の貸借新規成約高詳細

主市場業種証券コード/EDINET英名称
東証GRT医薬品4582/E24682-
公表日公表担保新規貸付前週比新規借入(自己)前週比新規借入(転貸)前週比
2018/08/03日証協無担保0株0%0株0%25,800株-21.58%
2018/08/03日証協有担保4,956,874株+164.72%56,400株-42.54%496,700株+40.97%
2018/07/27日証協無担保0株0%0株0%32,900株+0.92%
2018/07/27日証協有担保1,872,502株-14.58%98,160株+378.83%352,340株+226.85%
2018/07/20日証協無担保0株0%0株0%32,600株-41.47%
2018/07/20日証協有担保2,192,024株+30.18%20,500株-40.75%107,800株-1.91%
2018/07/13日証協無担保0株0%0株0%55,701株-27.94%
2018/07/13日証協有担保1,683,819株-37.86%34,600株-86.27%109,900株-86.69%
2018/07/06日証協無担保0株0%0株0%77,300株+152.61%
2018/07/06日証協有担保2,709,620株+38.9%252,040株+81.19%825,400株+2077.84%
2018/06/29日証協無担保0株0%0株0%30,600株-5.85%
2018/06/29日証協有担保1,950,798株-38.69%139,100株+203.71%37,900株-94.03%
2018/06/22日証協無担保0株0%0株0%32,500株-64.29%
2018/06/22日証協有担保3,181,916株+674.91%45,800株-46.56%635,300株+502.18%
2018/06/15日証協無担保0株-100%0株0%91,000株+34.18%
2018/06/15日証協有担保410,617株-88.74%85,700株+632.48%105,500株-79.54%
2018/06/08日証協無担保95,400株0%0株0%67,820株+70.4%
2018/06/08日証協有担保3,645,427株+355.47%11,700株-91.8%515,766株-48.87%
2018/06/01日証協無担保0株0%0株0%39,800株+55.47%
2018/06/01日証協有担保800,366株+545.32%142,734株+67.53%1,008,666株+1744%
2018/05/25日証協無担保0株0%0株0%25,600株-52.15%
2018/05/25日証協有担保124,027株-88.46%85,200株-32.91%54,700株+4872.73%
2018/05/18日証協無担保0株-100%0株0%53,500株+8.52%
2018/05/18日証協有担保1,075,118株-6.31%127,000株+102.55%1,100株-97.28%
2018/05/11日証協無担保12,000株-53.12%0株0%49,300株+12.56%
2018/05/11日証協有担保1,147,574株+126.12%62,700株+6.45%40,400株-58.61%
2018/05/02日証協無担保25,600株-79.84%0株0%43,800株-4.58%
2018/05/02日証協有担保507,500株-76.69%58,900株-31.67%97,600株-75.75%
2018/04/27日証協無担保127,000株0%0株0%45,900株+51.24%
2018/04/27日証協有担保2,177,500株+15.78%86,200株-74.91%402,400株-44.4%
2018/04/20日証協無担保0株0%0株0%30,349株-18.42%
2018/04/20日証協有担保1,880,700株+18.19%343,500株+89.26%723,800株+52.8%
2018/04/13日証協無担保0株0%0株0%37,200株+132.21%
2018/04/13日証協有担保1,591,224株+97.94%181,500株0%473,700株+618.82%
2018/04/06日証協無担保0株0%0株0%16,020株-44.27%
2018/04/06日証協有担保803,902株-54.04%0株0%65,900株-56.27%
2018/03/30日証協無担保0株0%0株0%28,747株+5.3%
2018/03/30日証協有担保1,749,102株+81.75%0株-100%150,700株-61.87%

※株式分割は考慮していませんのでご注意ください。

Page Top